About: Chapter 45. Percutaneous coronary interventions in patients with acute coronary syndromes     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Three different guidelines of the European Society of Cardiology (ESC) cover the field of percutaneous coronary interventions (PCI). Their main recommendations are the following: All patients with ST-segment elevation myocardial infarction (STEMI) should undergo immediate coronary angiography and PCI as soon as possible after first medical contact. Thrombolysis can be used as alternative reperfusion therapy only for patients presenting early (<3 h from symptom onset) with expected time to PCI longer than 60-90 min. Patients with high risk non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) (recurrent or ongoing chest pain, profound or dynamic ECG changes, major arrhythmias, or haemodynamic instability) should undergo coronary angiography within <2 h after the initial hospital admission. Moderate risk NSTE ACS patients should undergo coronary angiography within <3 days after the initial hospital admission. Low risk NSTE ACS patients may be treated conservatively and the decision on invasive evaluation can be based on evidence of ischaemia during exercise stress testing. Stents should be used during all PCI procedures whenever technically feasible. Drug-eluting stents decrease the risk of restenosis, but do not influence mortality when compared with bare metal stents. Triple pharmacotherapy (most frequently aspirin, clopidogrel, and heparin or their therapeutic equivalents) should be used in all PCI procedures, with GPIIb/IIIa inhibitors added in patients with high thrombotic and low bleeding risk.
  • Three different guidelines of the European Society of Cardiology (ESC) cover the field of percutaneous coronary interventions (PCI). Their main recommendations are the following: All patients with ST-segment elevation myocardial infarction (STEMI) should undergo immediate coronary angiography and PCI as soon as possible after first medical contact. Thrombolysis can be used as alternative reperfusion therapy only for patients presenting early (<3 h from symptom onset) with expected time to PCI longer than 60-90 min. Patients with high risk non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) (recurrent or ongoing chest pain, profound or dynamic ECG changes, major arrhythmias, or haemodynamic instability) should undergo coronary angiography within <2 h after the initial hospital admission. Moderate risk NSTE ACS patients should undergo coronary angiography within <3 days after the initial hospital admission. Low risk NSTE ACS patients may be treated conservatively and the decision on invasive evaluation can be based on evidence of ischaemia during exercise stress testing. Stents should be used during all PCI procedures whenever technically feasible. Drug-eluting stents decrease the risk of restenosis, but do not influence mortality when compared with bare metal stents. Triple pharmacotherapy (most frequently aspirin, clopidogrel, and heparin or their therapeutic equivalents) should be used in all PCI procedures, with GPIIb/IIIa inhibitors added in patients with high thrombotic and low bleeding risk. (en)
Title
  • Chapter 45. Percutaneous coronary interventions in patients with acute coronary syndromes
  • Chapter 45. Percutaneous coronary interventions in patients with acute coronary syndromes (en)
skos:prefLabel
  • Chapter 45. Percutaneous coronary interventions in patients with acute coronary syndromes
  • Chapter 45. Percutaneous coronary interventions in patients with acute coronary syndromes (en)
skos:notation
  • RIV/00064173:_____/11:00002865!RIV13-MZ0-00064173
http://linked.open...avai/predkladatel
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • V, Z(MSM0021620816)
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 189912
http://linked.open...ai/riv/idVysledku
  • RIV/00064173:_____/11:00002865
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • percutaneous coronary intervention; acute coronary syndromes (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...ontrolniKodProRIV
  • [E9DB73122E19]
http://linked.open...i/riv/mistoVydani
  • Oxford
http://linked.open...i/riv/nazevZdroje
  • The ESC Textbook of Intensive and Acute Cardiac Care
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...v/pocetStranKnihy
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Kočka, Viktor
  • Toušek, Petr
  • Widimský, Petr
http://linked.open...n/vavai/riv/zamer
number of pages
http://purl.org/ne...btex#hasPublisher
  • Oxford University Press
https://schema.org/isbn
  • 978-0-19-958431-4
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software